250 related articles for article (PubMed ID: 36359740)
1. Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing's Disease.
Chakrabarti J; Pandey R; Churko JM; Eschbacher J; Mallick S; Chen Y; Hermes B; Mallick P; Stansfield BN; Pond KW; Thorne CA; Yuen KCJ; Little AS; Zavros Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359740
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
Mallick S; Chakrabarti J; Eschbacher J; Moraitis AG; Greenstein AE; Churko J; Pond KW; Livolsi A; Thorne CA; Little AS; Yuen KCJ; Zavros Y
Transl Res; 2023 Jun; 256():56-72. PubMed ID: 36640905
[TBL] [Abstract][Full Text] [Related]
3. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract][Full Text] [Related]
4. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
5. Recurrent Cushing's Disease Caused by a TPIT-Lineage Densely Granulated Corticotroph Pituitary Neuroendocrine Tumor: A Case Report.
Wu W; Fu X; Guo W; Chen H
Neuro Endocrinol Lett; 2024 Jan; 45(1):76-80. PubMed ID: 38295430
[TBL] [Abstract][Full Text] [Related]
6. Medical treatment of Cushing's Disease.
Cuevas-Ramos D; Fleseriu M
Minerva Endocrinol; 2016 Sep; 41(3):324-40. PubMed ID: 26977887
[TBL] [Abstract][Full Text] [Related]
7. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
[TBL] [Abstract][Full Text] [Related]
8. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
10. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
11. Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.
Rak B; Maksymowicz M; Pękul M; Zieliński G
Front Endocrinol (Lausanne); 2021; 12():672178. PubMed ID: 34135861
[TBL] [Abstract][Full Text] [Related]
12. Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.
Pivonello R; Ferrigno R; De Martino MC; Simeoli C; Di Paola N; Pivonello C; Barba L; Negri M; De Angelis C; Colao A
Front Endocrinol (Lausanne); 2020; 11():648. PubMed ID: 33363514
[TBL] [Abstract][Full Text] [Related]
13. Cushing's disease -- assessing the efficacy of transsphenoidal surgery.
Witek P; Zieliński G; Maksymowicz M; Kamiński G
Endokrynol Pol; 2012; 63(5):398-404. PubMed ID: 23115075
[TBL] [Abstract][Full Text] [Related]
14. PPAR-gamma in Cushing's disease.
Heaney AP
Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
[TBL] [Abstract][Full Text] [Related]
15. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
Suri D; Weiss RE
J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
[TBL] [Abstract][Full Text] [Related]
16. [Development of sarcoidosis after successful treatment of Cushing's disease].
Zakharova PA; Ilovayskaya IA; Terpigorev SA; Komerdus IV; Lugovskaya AY
Probl Endokrinol (Mosk); 2024 Jan; 69(6):47-53. PubMed ID: 38311994
[TBL] [Abstract][Full Text] [Related]
17. The dopaminergic control of Cushing's syndrome.
Pivonello R; Pivonello C; Simeoli C; De Martino MC; Colao A
J Endocrinol Invest; 2022 Jul; 45(7):1297-1315. PubMed ID: 35460460
[TBL] [Abstract][Full Text] [Related]
18. Unusual ectopic ACTH syndrome in a patient with orbital neuroendocrine tumor, resulted false-positive outcome of BIPSS:a case report.
Tan H; Chen D; Yu Y; Yu K; He W; Cai B; Jiang S; Tang Y; Tong N; An Z
BMC Endocr Disord; 2020 Jul; 20(1):116. PubMed ID: 32736557
[TBL] [Abstract][Full Text] [Related]
19. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
